Innovation opportunities offer the promise of transforming how we treat patients for better outcomes and efficiency. The Oxford AHSN Clinical Innovation Adoption team has introduced innovation into the NHS successfully by understanding priorities, clinical need, identifying best in class innovation, supporting successful implementation and enabling NHS organisations to sustain change. Involvement and ownership by patients, frontline staff and industry in this process is key. We are responsive to the uniqueness of each project and adapt support to optimise success.
Since 2013 our programme has been working to respond to continuing growth in demand on the NHS. Since the publication of the government Accelerated Access Review in October 2016, AHSNs and innovation have been focal points for both NHS transformation and life science growth.
Meet The Team
Tracey Marriott, Director of Clinical Innovation Adoption, is an MBA qualified commercial and transformational change professional with over 15 years’ experience within the private and public health sector. She has extensive experience of delivering complex programmes regionally, nationally and across Europe (budget values up to £1.6billion). Tracey manages the Clinical Innovation Adoption team and works closely with the Oxford AHSN Strategic and Industry Partnership team to support the NHS and industry with adoption of innovation.
Hannah has extensive experience of the NHS acute sector, having worked for many years in both operational and strategic management roles at acute trusts. With a background in biochemistry she has a keen interest in how life sciences research can translate to innovations in clinical care.
Ferdinand supports the Clinical Innovation Adoption team and has over 10 years’ experience working within the administrative setting. He has been working in the NHS since 2010 working within Acute, Community and Mental Health settings. Outside of work, Ferdinand is a big fan of basketball.
James has been working in the life science sector for ten years in roles in both R&D and market access. James has worked in discovery and development roles and has a PhD in Pharmacy from the University of Nottingham in which he investigated the barriers to adoption and reimbursement of biologic therapies. James has been leading on several projects to support the uptake of innovative drugs, biologics, medical devices and diagnostics in the NHS.
Alison has over fifteen years’ experience in the NHS working in senior acute operational roles. She has extensive experience liaising with clinical teams and commissioners, working across organisations to improve patient pathways and in delivering change management programmes.